Global and Europe Antitumor Drugs of Hormone Class Market - Analysis and Outlook to 2022

Published: Aug, 2017 | Pages: 111 | Publisher: EU Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report presents a comprehensive overview of the Antitumor Drugs of Hormone Class market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antitumor Drugs of Hormone Class industry.

This report focuses Global and Europe market,  including details as following:

Key Players
    CIPLA LIMITED IN 400 013 Mumbai
    DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad
    OLON S.P.A. IT 20090 Rodano
    MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad
    APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore
    EXCELLA GMBH & CO. KG DE 90537 Feucht
    ...

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Key Product Type
Antitumor Drugs of Hormone Class Market, by Hormone Class
    Exemestane
    Raloxifene
    Letrozole
    Fulvestrant
    Anastrozole
    Flutamide
    Droloxifene
    Idoxifene
    Formestane
    Aminoglutethimide
    Nilutamide
    Tamoxifen
    Toremifene
    Aminoglutethimide
Key Applications
    Oncology Department
    Hospital
    Department of Chemotherapy
    Pharmacology

 Table of Contents

Global and Europe Antitumor Drugs of Hormone Class Market - Analysis and Outlook to 2022
1 Market Outline
    1.1 Research Methodology
        1.1.1 Methodology/Research Approach
            Research Programs/Design
            Market Size Estimation
            Market Breakdown and Data Triangulation
        1.1.2 Data Source
            Secondary Sources
            Primary Sources
        1.1.3 Disclaimer
    1.2 Regulatory Factors
    1.3 End-User Analysis
    1.4 Strategic Benchmarking
    1.5 Industry Chain and Supply Chain
        1.5.1 Antitumor Drugs of Hormone Class Industry Chain Structure
            1.5.1.1 R&D
            1.5.1.2 Raw Materials (Components)
            1.5.1.3 Manufacturing Plants
            1.5.1.4 Regional Trading (Import Export and Local Sales)
            1.5.1.5 Online Sales Channel
            1.5.1.6 Offline Channel
            1.5.1.7 End Users
        1.5.2 Antitumor Drugs of Hormone Class Manufacturing
            1.5.2.1 Key Components
            1.5.2.2 Assembly Manufacturing
        1.5.3 Consumer Preference
        1.5.4 Behavioral Habits
        1.5.5 Marketing Environment
    1.6 SWOT Analysis
    1.7 Feasibility Analysis
    1.8 Development Trend and Research Conclusion
        1.8.1 Development Trend
        1.8.2 Research Conclusion

2 Global Antitumor Drugs of Hormone Class Product Overview
    2.1 Global Antitumor Drugs of Hormone Class Market Sales Volume Revenue and Price 2012-2017
    2.2 Antitumor Drugs of Hormone Class, by Hormone Class 2012-2017
        2.2.1 Global Antitumor Drugs of Hormone Class Sales Market Share by Hormone Class 2012-2017
        2.2.2 Global Antitumor Drugs of Hormone Class Revenue Market Share by Hormone Class 2012-2017
        2.2.3 Global Antitumor Drugs of Hormone Class Price by Hormone Class 2012-2017
        2.2.4 Exemestane
        2.2.5 Raloxifene
        2.2.6 Letrozole
        2.2.7 Fulvestrant
        2.2.8 Anastrozole
              Flutamide
              Droloxifene
              Idoxifene
              Formestane
              Aminoglutethimide
              Nilutamide
              Tamoxifen
              Toremifene
              Aminoglutethimide

3 Europe Antitumor Drugs of Hormone Class Product Overview
    3.1 Europe Antitumor Drugs of Hormone Class Market Sales Volume Revenue and Price 2012-2017
    3.2 Antitumor Drugs of Hormone Class, by Hormone Class 2012-2017
        3.2.1 Europe Antitumor Drugs of Hormone Class Sales Market Share by Hormone Class 2012-2017
        3.2.2 Europe Antitumor Drugs of Hormone Class Revenue Market Share by Hormone Class 2012-2017
        3.2.3 Europe Antitumor Drugs of Hormone Class Price by Hormone Class 2012-2017
        3.2.4 Exemestane
        3.2.5 Raloxifene
        3.2.6 Letrozole
        3.2.7 Fulvestrant
        3.2.8 Anastrozole
              Flutamide
              Droloxifene
              Idoxifene
              Formestane
              Aminoglutethimide
              Nilutamide
              Tamoxifen
              Toremifene
              Aminoglutethimide

4 Antitumor Drugs of Hormone Class Top Companies Profile
    4.1 CIPLA LIMITED IN 400 013 Mumbai
        4.1.1 CIPLA LIMITED IN 400 013 Mumbai Company Details and Competitors
        4.1.2 CIPLA LIMITED IN 400 013 Mumbai Key Antitumor Drugs of Hormone Class Models and Performance
        4.1.3 CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
        4.1.4 CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Sales Volume Revenue Price Cost and Gross Margin
    4.2 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad
        4.2.1 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Company Details and Competitors
        4.2.2 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Key Antitumor Drugs of Hormone Class Models and Performance
        4.2.3 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
        4.2.4 DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Sales Volume Revenue Price Cost and Gross Margin
    4.3 OLON S.P.A. IT 20090 Rodano
        4.3.1 OLON S.P.A. IT 20090 Rodano Company Details and Competitors
        4.3.2 OLON S.P.A. IT 20090 Rodano Key Antitumor Drugs of Hormone Class Models and Performance
        4.3.3 OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
        4.3.4 OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Sales Volume Revenue Price Cost and Gross Margin
    4.4 MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad
        4.4.1 MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Company Details and Competitors
        4.4.2 MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Key Antitumor Drugs of Hormone Class Models and Performance
        4.4.3 MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
        4.4.4 MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Sales Volume Revenue Price Cost and Gross Margin
    4.5 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore
        4.5.1 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Company Details and Competitors
        4.5.2 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Key Antitumor Drugs of Hormone Class Models and Performance
        4.5.3 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
        4.5.4 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Sales Volume Revenue Price Cost and Gross Margin
    4.6 EXCELLA GMBH & CO. KG DE 90537 Feucht
        4.6.1 EXCELLA GMBH & CO. KG DE 90537 Feucht Company Details and Competitors
        4.6.2 EXCELLA GMBH & CO. KG DE 90537 Feucht Key Antitumor Drugs of Hormone Class Models and Performance
        4.6.3 EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
        4.6.4 EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Sales Volume Revenue Price Cost and Gross Margin
    ...

5 Antitumor Drugs of Hormone Class by Regions 2012-2017
    5.1 Global Antitumor Drugs of Hormone Class Sales Market Share by Regions 2012-2017
    5.2 Global Antitumor Drugs of Hormone Class Revenue Market Share by Regions 2012-2017
    5.3 Global Antitumor Drugs of Hormone Class Price by Regions 2012-2017
    5.4 North America
        5.4.1 United States
        5.4.2 Canada
    5.5 Latin America
        5.5.1 Mexico
        5.5.2 Brazil
        5.5.3 Argentina
        5.5.4 Others in Latin America
    5.6 Europe
        5.6.1 Germany
        5.6.2 United Kingdom
        5.6.3 France
        5.6.4 Italy
        5.6.5 Spain
        5.6.6 Russia
        5.6.7 Netherland
        5.6.8 Others in Europe
    5.7 Asia & Pacific
        5.7.1 China
        5.7.2 Japan
        5.7.3 India
        5.7.4 Korea
        5.7.5 Australia
        5.7.6 Southeast Asia
            5.7.6.1 Indonesia
            5.7.6.2 Thailand
            5.7.6.3 Philippines
            5.7.6.4 Vietnam
            5.7.6.5 Singapore
            5.7.6.6 Malaysia
            5.7.6.7 Others in Southeast Asia
    5.8 Africa & Middle East
        5.8.1 South Africa
        5.8.2 Egypt
        5.8.3 Turkey
        5.8.4 Saudi Arabia
        5.8.5 Iran
        5.8.6 Others in Africa & Middle East

6 GlobalAntitumor Drugs of Hormone Class by Players 2012-2017
    6.1 Global Antitumor Drugs of Hormone Class Sales Volume Market Share by Brands 2012-2017
    6.2 Global Antitumor Drugs of Hormone Class Revenue Share by Brands 2012-2017
    6.3 Global Top Players Antitumor Drugs of Hormone Class Key Product Model and Market Performance
    6.4 Global Top Players Antitumor Drugs of Hormone Class Key Target Consumers and Market Performance

7 EuropeAntitumor Drugs of Hormone Class by Players 2012-2017
    7.1 Europe Antitumor Drugs of Hormone Class Sales Volume Market Share by Brands 2012-2017
    7.2 Europe Antitumor Drugs of Hormone Class Revenue Share by Brands 2012-2017
    7.3 Europe Top Players Antitumor Drugs of Hormone Class Key Product Model and Market Performance
    7.4 Europe Top Players Antitumor Drugs of Hormone Class Key Target Consumers and Market Performance

8 Global Antitumor Drugs of Hormone Class by Consumer 2012-2017
    8.1 Global Antitumor Drugs of Hormone Class Sales Market Share by Consumer 2012-2017
    8.2 Oncology Department
    8.3 Hospital
    8.4 Department of Chemotherapy
    8.5 Pharmacology
    8.6 Consuming Habit and Preference

9 Europe Antitumor Drugs of Hormone Class by Consumer 2012-2017
    9.1 Europe Antitumor Drugs of Hormone Class Sales Market Share by Consumer 2012-2017
    9.2 Oncology Department
    9.3 Hospital
    9.4 Department of Chemotherapy
    9.5 Pharmacology
    9.6 Consuming Habit and Preference

10 Global Antitumor Drugs of Hormone Class Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Antitumor Drugs of Hormone Class Sales (), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Antitumor Drugs of Hormone Class Sales () Forecast by Regions (2017-2022)
    10.3 Global Antitumor Drugs of Hormone Class Sales () Forecast by Application (2017-2022)
    10.4 Global Antitumor Drugs of Hormone Class Sales () Forecast by Hormone Class (2017-2022)
    10.5 Global Antitumor Drugs of Hormone Class Sales () Forecast by  (2017-2022)

11 Europe Antitumor Drugs of Hormone Class Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 Europe Antitumor Drugs of Hormone Class Sales (), Revenue (Million USD) Forecast (2017-2022)
    11.2 Europe Antitumor Drugs of Hormone Class Sales () Forecast by Regions (2017-2022)
    11.3 Europe Antitumor Drugs of Hormone Class Sales () Forecast by Application (2017-2022)
    11.4 Europe Antitumor Drugs of Hormone Class Sales () Forecast by Hormone Class (2017-2022)
    11.5 Europe Antitumor Drugs of Hormone Class Sales () Forecast by  (2017-2022)

List of Tables and Figures

    Table Global Antitumor Drugs of Hormone Class Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales Volume () and Growth Rate (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales () by Hormone Class (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales Market Share by Hormone Class (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales Market Share by Hormone Class in 2016
    Table Global Antitumor Drugs of Hormone Class Revenue (Million USD) by Hormone Class (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Revenue Market Share by Hormone Class (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Revenue Market Share by Hormone Class in 2016
    Table Global Antitumor Drugs of Hormone Class Price () by Hormone Class (2012-2017)
    Table Top Players of Exemestane Antitumor Drugs of Hormone Class Products List
    Figure Global Exemestane Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Raloxifene Antitumor Drugs of Hormone Class Products List
    Figure Global Raloxifene Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Letrozole Antitumor Drugs of Hormone Class Products List
    Figure Global Letrozole Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Fulvestrant Antitumor Drugs of Hormone Class Products List
    Figure Global Fulvestrant Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Anastrozole Antitumor Drugs of Hormone Class Products List
    Figure Global Anastrozole Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales () by  (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales Market Share by  in 2016
    Table Global Antitumor Drugs of Hormone Class Revenue (Million USD) by  (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Revenue Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Revenue Market Share by  in 2016
    Table Global Antitumor Drugs of Hormone Class Price () by  (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales () by  (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales Market Share by  in 2016
    Table Global Antitumor Drugs of Hormone Class Revenue (Million USD) by  (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Revenue Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Revenue Market Share by  in 2016
    Table Global Antitumor Drugs of Hormone Class Price () by  (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales () by Hormone Class (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales Market Share by Hormone Class (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Sales Market Share by Hormone Class in 2016
    Table Europe Antitumor Drugs of Hormone Class Revenue (Million USD) by Hormone Class (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Revenue Market Share by Hormone Class (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Revenue Market Share by Hormone Class in 2016
    Table Europe Antitumor Drugs of Hormone Class Price () by Hormone Class (2012-2017)
    Table Top Players of Exemestane Antitumor Drugs of Hormone Class Products List
    Figure Europe Exemestane Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Raloxifene Antitumor Drugs of Hormone Class Products List
    Figure Europe Raloxifene Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Letrozole Antitumor Drugs of Hormone Class Products List
    Figure Europe Letrozole Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Fulvestrant Antitumor Drugs of Hormone Class Products List
    Figure Europe Fulvestrant Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Top Players of Anastrozole Antitumor Drugs of Hormone Class Products List
    Figure Europe Anastrozole Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales () by  (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Sales Market Share by  in 2016
    Table Europe Antitumor Drugs of Hormone Class Revenue (Million USD) by  (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Revenue Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Revenue Market Share by  in 2016
    Table Europe Antitumor Drugs of Hormone Class Price () by  (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales () by  (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Sales Market Share by  in 2016
    Table Europe Antitumor Drugs of Hormone Class Revenue (Million USD) by  (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Revenue Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Revenue Market Share by  in 2016
    Table Europe Antitumor Drugs of Hormone Class Price () by  (2012-2017)
    Table CIPLA LIMITED IN 400 013 Mumbai Company Details and Competitors
    Table CIPLA LIMITED IN 400 013 Mumbai Key Antitumor Drugs of Hormone Class Models and Performance
    Table CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
    Table CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Sales Market Share (%) in Global (2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Antitumor Drugs of Hormone Class Revenue Market Share (%) in Global (2012-2017)
    Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Company Details and Competitors
    Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Key Antitumor Drugs of Hormone Class Models and Performance
    Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
    Table DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Sales Market Share (%) in Global (2012-2017)
    Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad Antitumor Drugs of Hormone Class Revenue Market Share (%) in Global (2012-2017)
    Table OLON S.P.A. IT 20090 Rodano Company Details and Competitors
    Table OLON S.P.A. IT 20090 Rodano Key Antitumor Drugs of Hormone Class Models and Performance
    Table OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
    Table OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Sales Market Share (%) in Global (2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Hormone Class Revenue Market Share (%) in Global (2012-2017)
    Table MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Company Details and Competitors
    Table MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Key Antitumor Drugs of Hormone Class Models and Performance
    Table MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
    Table MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Sales Market Share (%) in Global (2012-2017)
    Figure MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad Antitumor Drugs of Hormone Class Revenue Market Share (%) in Global (2012-2017)
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Company Details and Competitors
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Key Antitumor Drugs of Hormone Class Models and Performance
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Sales Market Share (%) in Global (2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Antitumor Drugs of Hormone Class Revenue Market Share (%) in Global (2012-2017)
    Table EXCELLA GMBH & CO. KG DE 90537 Feucht Company Details and Competitors
    Table EXCELLA GMBH & CO. KG DE 90537 Feucht Key Antitumor Drugs of Hormone Class Models and Performance
    Table EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Business SWOT Analysis and Forecast
    Table EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Sales Market Share (%) in Global (2012-2017)
    Figure EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure EXCELLA GMBH & CO. KG DE 90537 Feucht Antitumor Drugs of Hormone Class Revenue Market Share (%) in Global (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales () by Regions (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales Share by Regions (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales Market Share by Regions in 2016
    Figure Global Antitumor Drugs of Hormone Class Sales Market Share by Regions in 2017
    Table Global Antitumor Drugs of Hormone Class Revenue (Million USD) by Regions (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Revenue Market Share by Regions (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Revenue Market Share by Regions in 2016
    Figure Global Antitumor Drugs of Hormone Class Revenue Market Share by Regions in 2017
    Table Global Antitumor Drugs of Hormone Class Price () by Regions (2012-2017)
    Table North America Antitumor Drugs of Hormone Class Sales () by Regions (2012-2017)
    Table North America Antitumor Drugs of Hormone Class Revenue (Million USD) by Regions (2012-2017)
    Figure North America Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Latin America Antitumor Drugs of Hormone Class Sales () by Regions (2012-2017)
    Table Latin America Antitumor Drugs of Hormone Class Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales () by Regions (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Antitumor Drugs of Hormone Class Sales () by Regions (2012-2017)
    Table Asia & Pacific Antitumor Drugs of Hormone Class Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Antitumor Drugs of Hormone Class Sales () by Regions (2012-2017)
    Table Africa & Middle East Antitumor Drugs of Hormone Class Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Global Antitumor Drugs of Hormone Class Sales Volume () by Key Players 2012-2017
    Table Global Antitumor Drugs of Hormone Class Sales Volume Market Share by Key Players 2012-2017
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Market Share by Key Players 2016
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Market Share by Key Players 2017
    Table Global Antitumor Drugs of Hormone Class Revenue (Million USD) by Key Players 2012-2017
    Table Global Antitumor Drugs of Hormone Class Revenue Market Share by Key Players 2012-2017
    Figure Global Antitumor Drugs of Hormone Class Revenue Market Share by Key Players 2016
    Figure Global Antitumor Drugs of Hormone Class Revenue Market Share by Key Players 2017
    Table Global Top Players Key Product Model and Market Performance
    Table Global Top Players Key Target Consumers and Market Performance
    Table Europe Antitumor Drugs of Hormone Class Sales Volume () by Key Players 2012-2017
    Table Europe Antitumor Drugs of Hormone Class Sales Volume Market Share by Key Players 2012-2017
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Market Share by Key Players 2016
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Market Share by Key Players 2017
    Table Europe Antitumor Drugs of Hormone Class Revenue (Million USD) by Key Players 2012-2017
    Table Europe Antitumor Drugs of Hormone Class Revenue Market Share by Key Players 2012-2017
    Figure Europe Antitumor Drugs of Hormone Class Revenue Market Share by Key Players 2016
    Figure Europe Antitumor Drugs of Hormone Class Revenue Market Share by Key Players 2017
    Table Europe Top Players Key Product Model and Market Performance
    Table Europe Top Players Key Target Consumers and Market Performance
    Table Global Antitumor Drugs of Hormone Class Sales () by Consumer (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales Market Share by Consumer (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales Market Share by Consumer in 2016
    Figure Global Oncology Department Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Figure Global Hospital Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Figure Global Department of Chemotherapy Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Figure Global Pharmacology Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Hormone Class Sales () by Consumer (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Sales Market Share by Consumer (2012-2017)
    Figure Europe Antitumor Drugs of Hormone Class Sales Market Share by Consumer in 2016
    Figure Europe Oncology Department Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Figure Europe Hospital Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Figure Europe Department of Chemotherapy Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Figure Europe Pharmacology Antitumor Drugs of Hormone Class Sales () and Growth Rate (2012-2017)
    Figure Global Antitumor Drugs of Hormone Class Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Price () Trend Forecast (2017-2022)
    Table Global Antitumor Drugs of Hormone Class Sales () Forecast by Regions (2017-2022)
    Table Global Antitumor Drugs of Hormone Class Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Share Forecast by Regions in 2022
    Table Global Antitumor Drugs of Hormone Class Sales () Forecast by Application (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by Application in 2022
    Table Global Antitumor Drugs of Hormone Class Sales () Forecast by Hormone Class (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales () Forecast by Hormone Class (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by Hormone Class in 2022
    Table Global Antitumor Drugs of Hormone Class Sales () Forecast by  (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales () Forecast by  (2017-2022)
    Figure Global Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by  in 2022
    Figure Europe Antitumor Drugs of Hormone Class Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Price () Trend Forecast (2017-2022)
    Table Europe Antitumor Drugs of Hormone Class Sales () Forecast by Regions (2017-2022)
    Table Europe Antitumor Drugs of Hormone Class Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Share Forecast by Regions in 2022
    Table Europe Antitumor Drugs of Hormone Class Sales () Forecast by Application (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by Application in 2022
    Table Europe Antitumor Drugs of Hormone Class Sales () Forecast by Hormone Class (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales () Forecast by Hormone Class (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by Hormone Class in 2022
    Table Europe Antitumor Drugs of Hormone Class Sales () Forecast by  (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales () Forecast by  (2017-2022)
    Figure Europe Antitumor Drugs of Hormone Class Sales Volume Market Share Forecast by  in 2022